Sign In
Buy BIO
$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
Top Healthcare Stocks for February 2021
02:15pm, Tuesday, 19'th Jan 2021
These are the healthcare stocks with the best value, fastest growth, and most momentum for February 2021.
A Trio of High Earnings Return Stocks
10:51am, Sunday, 10'th Jan 2021
If you pick securities whose earnings return is more than twice that of the 20-year high-quality market corporate bonds, you could increase your probability to unearth value opportunities, in my opini
Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11
08:30am, Friday, 08'th Jan 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, Pre
Robot Portfolio Chugs Along, Seeking to Regain Past Glory
02:52pm, Monday, 04'th Jan 2021
"Why do you like tobacco stocks so much?" my colleague asked our boss, David Dreman (Trades, Portfolio), about two decades ago.
Can the Bunny Come Roaring Back?
10:58am, Monday, 14'th Dec 2020
Perhaps you've seen the Energizer Bunny in a battery commercial. It is "still going" long after you'd expect it to fade.
Bio-Rad Provides Outlook Through 2023
05:33pm, Thursday, 10'th Dec 2020
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today its outlook through 2023,
Top Healthcare Stocks for December 2020
01:03pm, Thursday, 19'th Nov 2020
These are the healthcare stocks with the best value, fastest growth, and most momentum for December 2020.
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2020 Results - Earnings Call Transcript
03:41am, Friday, 30'th Oct 2020
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2020 Results - Earnings Call Transcript
Bio-Rad Laboratories: Q3 Earnings Insights
04:59pm, Thursday, 29'th Oct 2020
Shares of Bio-Rad Laboratories (NYSE:BIO) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 86.34% year over year to $3.00, which beat
Was The Smart Money Right About Crowding Into Bio-Rad Laboratories, Inc. (BIO)?
12:25am, Monday, 26'th Oct 2020
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in
The Global Capillary Electrophoresis Market will grow by $ 300.97 mn during 2020-2024
Bio-Rad Gains 16.2% Since September, Bullish Outlook Remains Strong (NYSE:BIO)
05:44pm, Monday, 19'th Oct 2020
Recent rally to all-time highs in October on the back of strong support this year, up 50.4% YTD. The stock has bounced from the support line 3-4 times since June, with potential new support drawn from
Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020
12:00am, Monday, 19'th Oct 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial resu
The Global Electroporation and Electrofusion Market will grow by $ 105.77 mn during 2020-2024
